Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

IMPC Phenotype

decreased fasted circulating g... 1 | 49
increased circulating HDL chol... 1 | 63

Disease

Cancer 6 | 2,346
Hypersensitivity reaction type II disease 5 | 235
psoriasis 5 | 6,685
Lung disease 4 | 136
Multiple Sclerosis 4 | 498
breast carcinoma 4 | 1,614
cutaneous lupus erythematosus 4 | 1,056
glioblastoma 4 | 5,572
interstitial cystitis 4 | 2,299
invasive ductal carcinoma 4 | 2,950
lung carcinoma 4 | 2,844
sarcoidosis 4 | 368
ulcerative colitis 4 | 2,087
Alopecia areata 3 | 37
Dermatitis 3 | 141
Hepatitis C 3 | 90
Hypersensitivity 3 | 63
Inflammatory bowel disease 3 | 142
Pneumonia 3 | 133
Vascular disease 3 | 281
active Crohn's disease 3 | 918
adult high grade glioma 3 | 2,148
atypical teratoid / rhabdoid tumor 3 | 4,369
colon cancer 3 | 1,475
juvenile dermatomyositis 3 | 1,189
nasopharyngeal carcinoma 3 | 1,056
pancreatic cancer 3 | 2,300
primary Sjogren syndrome 3 | 788
tuberculosis 3 | 1,563
Arthritis 2 | 248
Asthma 2 | 349
Autoimmune Diseases 2 | 33
Biliary cirrhosis 2 | 33
Breast cancer 2 | 3,098
Dermatitis, Atopic 2 | 45
Encephalitis 2 | 54
Eye disease 2 | 55
Hepatitis 2 | 61
Human immunodeficiency virus infectious disease 2 | 129
Hypertension 2 | 293
Influenza 2 | 142
Kidney disease 2 | 397
Lichen planus 2 | 17
Malaria 2 | 140
cystic fibrosis 2 | 1,670
ductal carcinoma in situ 2 | 1,745
head and neck cancer 2 | 270
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung adenocarcinoma 2 | 2,714
lung cancer 2 | 4,473
malignant mesothelioma 2 | 3,163
medulloblastoma, large-cell 2 | 6,234
mucosa-associated lymphoid tissue lymphoma 2 | 480
non-small cell lung carcinoma 2 | 413
posterior fossa group A ependymoma 2 | 1,511
Adenoma 1 | 165
Atherosclerosis 1 | 275
Brain Ischemia 1 | 87
COPD 1 | 116
Cerebrovascular accident 1 | 44
Cerebrovascular disease 1 | 231
Colonic Neoplasms 1 | 126
Contact Dermatitis 1 | 80
Coronary artery disease 1 | 240
Cryoglobulinemia 1 | 15
Cushing's syndrome 1 | 47
Dengue disease 1 | 19
Drug-Induced Liver Injury 1 | 118
Heart disease 1 | 279
Hepatitis B 1 | 103
Hyperparathyroidism 1 | 43
Inflammation 1 | 109
Irritable bowel syndrome 1 | 59
Liver disease 1 | 219
Mammary Neoplasms 1 | 410
Myocardial Ischemia 1 | 169
Neoplasm Recurrence, Local 1 | 23
Peripheral vascular disease 1 | 90
Pituitary adenoma 1 | 35
Pulmonary Embolism 1 | 45
Severe acute respiratory syndrome 1 | 26
Spontaneous abortion 1 | 108
Thrombocytopenia 1 | 105
Thrombophilia 1 | 37
adrenocortical adenoma 1 | 134
adrenocortical carcinoma 1 | 1,427
aldosterone-producing adenoma 1 | 664
astrocytoma 1 | 1,493
facioscapulohumeral dystrophy 1 | 286
hepatocellular carcinoma 1 | 550
inflammatory breast cancer 1 | 404
non-small cell lung cancer 1 | 2,798
ovarian cancer 1 | 8,491
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
urothelial carcinoma 1 | 318

Tissue

Blood and immune system 6 | 17,994
Cardiovascular System 6 | 17,957
Digestive Tract 6 | 18,472
Endocrine System 6 | 18,511
Female tissues 6 | 18,646
Liver and Pancreas 6 | 18,135
Male tissues 6 | 17,968
Nervous System 6 | 18,560
Respiratory system 6 | 17,483
Skin and soft tissues 6 | 18,114
Urinary Tract 6 | 18,443

Target Family

Non-IDG 5 | 11,969
GPCR 1 | 408

GO Process

positive regulation of cAMP me... 6 | 6
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 367 | 367
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
chemical synaptic transmission 238 | 238
MAPK cascade 237 | 237
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 199 | 199
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 180 | 180
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 175 | 175
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
protein folding 162 | 162
negative regulation of canonic... 161 | 161
response to lipopolysaccharide 161 | 161
T cell receptor signaling path... 160 | 160
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2-M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
type I interferon signaling pa... 130 | 130
endocytosis 129 | 129

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-X-C motif chemokine 11 CXCL11 Tbio Non-IDG -2.70030 491.1 279
C-X-C motif chemokine 9 CXCL9 Tbio Non-IDG -2.94746 860.6 317
C-X-C motif chemokine 10 CXCL10 Tchem Non-IDG -3.23299 1760.4 488
Platelet factor 4 PF4 Tbio Non-IDG -3.29725 2045.5 243
Chromogranin-A CHGA Tbio Non-IDG -3.35534 2149.2 1004
C-X-C chemokine receptor type 3 CXCR3 Tchem GPCR -2.89335 788.3 508